Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Kaye

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Neurology|October 1, 1989
Serial quantitative CT analysis of brain morphometrics in adult Down's syndrome at different agesM B Schapiro, J S Luxenberg, J A Kaye, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 28, 2006
Cortical excitability and age-related volumetric MRI changesL C Silbert, C Nelson, S Holman, et al.
Neurology|July 14, 2004
Predicting the rate of cognitive decline in aging and early Alzheimer diseaseS Adak, K Illouz, W Gorman, et al.
Neurology|February 13, 2002
A videotaped CIBIC for dementia patients: validity and reliability in a simulated clinical trialJ Quinn, M Moore, D F Benson, et al.
Neurology|November 30, 2007
Trajectories of brain loss in aging and the development of cognitive impairmentN E Carlson, M M Moore, A Dame, et al.
Neuroimage. Clinical|June 25, 2015
Characterizing the white matter hyperintensity penumbra with cerebral blood flow measuresN Promjunyakul, D Lahna, J A Kaye, et al.
The American Journal of Medicine|January 1, 1986
Malignant mesothelioma with brain metastasesJ A Kaye, A M Wang, C L Joachim, et al.
Brain Research|December 26, 1994
Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy studyP F Kwo-On-Yuen, R D Newmark, T F Budinger, et al.
Archives of Neurology|March 1, 1988
Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signsJ R Atack, M F Beal, C May, et al.
JAMA|May 4, 1994
Alzheimer's disease, apolipoprotein E4, and genderH Payami, K R Montee, J A Kaye, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Neurology|October 1, 1989
Serial quantitative CT analysis of brain morphometrics in adult Down's syndrome at different agesM B Schapiro, J S Luxenberg, J A Kaye, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 28, 2006
Cortical excitability and age-related volumetric MRI changesL C Silbert, C Nelson, S Holman, et al.
Neurology|July 14, 2004
Predicting the rate of cognitive decline in aging and early Alzheimer diseaseS Adak, K Illouz, W Gorman, et al.
Neurology|February 13, 2002
A videotaped CIBIC for dementia patients: validity and reliability in a simulated clinical trialJ Quinn, M Moore, D F Benson, et al.
Neurology|November 30, 2007
Trajectories of brain loss in aging and the development of cognitive impairmentN E Carlson, M M Moore, A Dame, et al.
Neuroimage. Clinical|June 25, 2015
Characterizing the white matter hyperintensity penumbra with cerebral blood flow measuresN Promjunyakul, D Lahna, J A Kaye, et al.
The American Journal of Medicine|January 1, 1986
Malignant mesothelioma with brain metastasesJ A Kaye, A M Wang, C L Joachim, et al.
Brain Research|December 26, 1994
Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy studyP F Kwo-On-Yuen, R D Newmark, T F Budinger, et al.
Archives of Neurology|March 1, 1988
Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signsJ R Atack, M F Beal, C May, et al.
JAMA|May 4, 1994
Alzheimer's disease, apolipoprotein E4, and genderH Payami, K R Montee, J A Kaye, et al.
Pageof 11